Who are we?
Probelte Pharma is a Spanish biopharmaceutical laboratory that specialises in the research, development, manufacture and marketing of diagnostic products and vaccines for allergen immunotherapy and specific bacterial auto-vaccines for human use. Founded in Murcia in 1995 by Antonio Belmonte Abellán, our company is a division of the Probelte group, which was formed in 1970.
Our work is based on the belief that health is a universal right and that advances in medicine must be sustainable and ethically responsible. This focus is about more than simply marketing our treatments; it is underpinned by the company´s commitment to science, safety and proximity to patients and healthcare professionals.
Our vision is to become a leader in the field of biopharmaceutical innovation, cementing our position as a company at the forefront of the development of vaccines and auto-vaccines. Our approach is not only technology-driven, but also people-centred. We are seeking to transform the industry through a model where innovation and research go hand in hand with empathy and commitment to people.
01
Foresight
Anticipating the medical challenges of the future by exploring new therapeutic solutions.
02
Development
Developing treatments that combine scientific rigour with a human touch.
03
Positioning
Positioning ourselves as a laboratory that sees health as something personal, tailoring our solutions to the individual needs of each patient.
Our mission is focused on three key pillars:
01
Innovation and scientific development
We develop safe and effective vaccines and auto-vaccines, using advanced technology to deliver high-quality treatments. We are also committed to ensuring that each of our products meets the highest standards of safety and efficacy.
02
Commitment to health and well-being
We work closely with healthcare professionals to ensure that our solutions are effective in clinical practice, with relationships based on transparency, trust and support, and promoting a model where scientific innovation and a personal approach go hand in hand.
03
Closeness and trust with the medical community
We develop treatments that improve the quality of life of patients, with the firm belief that health should be accessible to all, personalised and focused on people’s real needs. We are committed to more people-centred, ethical and sustainable medicine.
Our values are more than just words, they are principles that guide our every action:
Integrity and ethics
We adhere to strict safety and quality regulations, always acting transparently in our relationships with patients, healthcare professionals and partners.
Excellence and innovation
We continuously pursue new medical solutions to improve people's lives, striving for excellence at every stage of development, from research to production.
Commitment and well-being
We care about the impact of every decision we make on the community and the environment, and we are committed to sustainable and responsible innovation that proudly reflects our Murcian roots.
Caring and people-centred
We favour an approach in which each patient feels supported and understood, communicating in a clear and understandable way, without unnecessary jargon.
Identity
Probelte Pharma is not just a company, it is a community, and this human dimension is reflected in the design of our operational practices and talent management.
Belonging
A sense of belonging is a key pillar in the way we work, creating a culture of cooperation, respect and mutual commitment.
Probelte Pharma is a Spanish biopharmaceutical laboratory that specialises in the research, development, manufacture and marketing of diagnostic products and vaccines for allergen immunotherapy and specific bacterial auto-vaccines for human use. Founded in Murcia in 1995 by Antonio Belmonte Abellán, our company is a division of the Probelte group, which was formed in 1970.We are committed to continue growing and increasing our production both domestically and globally. We are currently present in Europe, Asia and South America. Our goal is to continue expanding to become an international leader in the sector.
Origins of the Probelte Group
Foundation of Probelte Pharma
Start of production of bacterial vaccines
Start of production of allergen vaccines
Opening of the state-of-the-art laboratory
Launch of KERIBA®
Marketing in Europe
Dust mite culturing
Acquisition of new facilities
Commitment to quality and global expansion
